Medical and Pharmaceutical bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction Shares rose by 73% during the session with no immediate catalyst Rowan DunneMarch 23, 2026
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan DunneMarch 9, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026
Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics Shares surged by 16% after the deal was announced Rowan DunneMarch 2, 2026
Medical and Pharmaceutical Allarity Therapeutics doses first patients in VA-funded small cell lung cancer trial The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment Rowan DunneFebruary 24, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan DunneFebruary 20, 2026
Medical and Pharmaceutical UBC scientists discover key to mass-producing helper T-cells for cancer treatment Cell therapies have gained ground in recent years as doctors turn patients’ immune systems into “living drugs.” Joseph MortonFebruary 18, 2026